When Medtronic Inc. completes its deal to buy Covidien Plc, it expects to be No. 1 or No. 2 in six of the top 10 categories for hospital purchases.
The U.S. company known mostly for developing sophisticated devices that shock the heart into beating properly is now becoming a Dublin-based generalist, broadening its focus to include Covidien’s everyday hospital supplies, a pact with the drugmaker Sanofi to develop care strategies for diabetics and opening heart catheterization labs in the U.K. and India.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
